- Home
- JFBR vs INM Comparison
JFBR vs INM Comparison
Compare JFBR & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFBR
- INM
- Stock Information
- Founded
- JFBR 2017
- INM 1981
- Country
- JFBR Israel
- INM Canada
- Employees
- JFBR N/A
- INM N/A
- Industry
- JFBR Other Specialty Stores
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- JFBR Consumer Discretionary
- INM Health Care
- Exchange
- JFBR Nasdaq
- INM Nasdaq
- Market Cap
- JFBR 3.6M
- INM 4.1M
- IPO Year
- JFBR 2022
- INM N/A
- Fundamental
- Price
- JFBR $1.91
- INM $1.70
- Analyst Decision
- JFBR
- INM
- Analyst Count
- JFBR 0
- INM 0
- Target Price
- JFBR N/A
- INM N/A
- AVG Volume (30 Days)
- JFBR 60.0K
- INM 61.5K
- Earning Date
- JFBR 09-22-2025
- INM 11-06-2025
- Dividend Yield
- JFBR N/A
- INM N/A
- EPS Growth
- JFBR N/A
- INM N/A
- EPS
- JFBR N/A
- INM N/A
- Revenue
- JFBR $14,474,000.00
- INM $4,798,116.00
- Revenue This Year
- JFBR N/A
- INM N/A
- Revenue Next Year
- JFBR N/A
- INM N/A
- P/E Ratio
- JFBR N/A
- INM N/A
- Revenue Growth
- JFBR 17.34
- INM N/A
- 52 Week Low
- JFBR $1.89
- INM $1.56
- 52 Week High
- JFBR $67.76
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- JFBR 22.95
- INM 36.70
- Support Level
- JFBR $2.10
- INM $1.59
- Resistance Level
- JFBR $2.33
- INM $1.91
- Average True Range (ATR)
- JFBR 0.24
- INM 0.10
- MACD
- JFBR -0.02
- INM 0.00
- Stochastic Oscillator
- JFBR 5.81
- INM 29.47
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank, Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon to identify existing stores, niches, and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.